252 related articles for article (PubMed ID: 30151991)
1. Enhanced motivation of cognitive control in Parkinson's disease.
Timmer MHM; Aarts E; Esselink RAJ; Cools R
Eur J Neurosci; 2018 Sep; 48(6):2374-2384. PubMed ID: 30151991
[TBL] [Abstract][Full Text] [Related]
2. Dopamine restores cognitive motivation in Parkinson's disease.
McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
[TBL] [Abstract][Full Text] [Related]
3. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
4. Motivation-cognition interaction: how feedback processing changes in healthy ageing and in Parkinson's disease.
Di Rosa E; Schiff S; Cagnolati F; Mapelli D
Aging Clin Exp Res; 2015 Dec; 27(6):911-20. PubMed ID: 25854302
[TBL] [Abstract][Full Text] [Related]
5. Computational Dissection of Dopamine Motor and Motivational Functions in Humans.
Le Bouc R; Rigoux L; Schmidt L; Degos B; Welter ML; Vidailhet M; Daunizeau J; Pessiglione M
J Neurosci; 2016 Jun; 36(25):6623-33. PubMed ID: 27335396
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
[TBL] [Abstract][Full Text] [Related]
7. The impact of Parkinson's disease and subthalamic deep brain stimulation on reward processing.
Evens R; Stankevich Y; Dshemuchadse M; Storch A; Wolz M; Reichmann H; Schlaepfer TE; Goschke T; Lueken U
Neuropsychologia; 2015 Aug; 75():11-9. PubMed ID: 25976111
[TBL] [Abstract][Full Text] [Related]
8. In Parkinson's disease STN stimulation enhances responsiveness of movement initiation speed to high reward value.
Kojovic M; Higgins A; Jahanshahi M
Neuropsychologia; 2016 Aug; 89():273-280. PubMed ID: 27371365
[TBL] [Abstract][Full Text] [Related]
9. Appetitive motivational deficits in individuals with Parkinson's disease.
Shore DM; Rafal R; Parkinson JA
Mov Disord; 2011 Aug; 26(10):1887-92. PubMed ID: 21520287
[TBL] [Abstract][Full Text] [Related]
10. Reward sensitivity in Parkinson's patients with binge eating.
Terenzi D; Rumiati RI; Catalan M; Antonutti L; Furlanis G; Garlasco P; Polverino P; Bertolotti C; Manganotti P; Aiello M
Parkinsonism Relat Disord; 2018 Jun; 51():79-84. PubMed ID: 29544881
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients.
Bogdanov M; LoParco S; Otto AR; Sharp M
Neurobiol Learn Mem; 2022 Sep; 193():107652. PubMed ID: 35724812
[TBL] [Abstract][Full Text] [Related]
12. Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease.
Dan R; Růžička F; Bezdicek O; Roth J; Růžička E; Vymazal J; Goelman G; Jech R
Eur Neuropsychopharmacol; 2019 Nov; 29(11):1258-1272. PubMed ID: 31607424
[TBL] [Abstract][Full Text] [Related]
13. The role of dopamine in the brain - lessons learned from Parkinson's disease.
Meder D; Herz DM; Rowe JB; Lehéricy S; Siebner HR
Neuroimage; 2019 Apr; 190():79-93. PubMed ID: 30465864
[TBL] [Abstract][Full Text] [Related]
14. Functional segregation of basal ganglia pathways in Parkinson's disease.
Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
[TBL] [Abstract][Full Text] [Related]
15. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss.
Aarts E; Helmich RC; Janssen MJ; Oyen WJ; Bloem BR; Cools R
Neuroimage; 2012 Feb; 59(4):3339-46. PubMed ID: 22166793
[TBL] [Abstract][Full Text] [Related]
16. Motivational engagement in Parkinson's disease: Preparation for motivated action.
Renfroe JB; Bradley MM; Okun MS; Bowers D
Int J Psychophysiol; 2016 Jan; 99():24-32. PubMed ID: 26659013
[TBL] [Abstract][Full Text] [Related]
17. Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.
Kojovic M; Mir P; Trender-Gerhard I; Schneider SA; Pareés I; Edwards MJ; Bhatia KP; Jahanshahi M
J Neurol; 2014 Jun; 261(6):1080-9. PubMed ID: 24687892
[TBL] [Abstract][Full Text] [Related]
18. Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing.
Martínez-Horta S; Riba J; de Bobadilla RF; Pagonabarraga J; Pascual-Sedano B; Antonijoan RM; Romero S; Mañanas MÀ; García-Sanchez C; Kulisevsky J
J Neurosci; 2014 Apr; 34(17):5918-26. PubMed ID: 24760851
[TBL] [Abstract][Full Text] [Related]
19. Dopamine enhances willingness to exert effort for reward in Parkinson's disease.
Chong TT; Bonnelle V; Manohar S; Veromann KR; Muhammed K; Tofaris GK; Hu M; Husain M
Cortex; 2015 Aug; 69():40-6. PubMed ID: 25967086
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic influences on risk preferences of Parkinson's disease patients.
Kobayashi S; Asano K; Matsuda N; Ugawa Y
Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
